Inventor · disambiguated record
Magnus Joakim Hansson
Also filed as: HANSSON MAGNUS · HANSSON MAGNUS JOAKIM
7 granted patents·4 pending applications·6 citations·filing 2013–2022
75Inventor score
Files withNEUROVIVE PHARMACEUTICAL AB5Abliva Ab4NEUROVIVE PHARMACEUTCAL AB1Neurovive Pharmaceuticals AB1
Top patents by PatentIndex Score
11 records- 0182US11565998B2Succinate prodrug, compositions containing the succinate prodrug and uses thereofAbliva Ab·Filed 2020·Granted Jan 31, 2023·2 cites·12 claims
- 0267US12162824B2Succinate prodrug, compositions containing the succinate prodrug and uses thereofAbliva Ab·Filed 2022·Granted Dec 10, 2024·0 cites·14 claims
- 0366US10307389B2Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylationNEUROVIVE PHARMACEUTICAL AB·Filed 2015·Granted Jun 4, 2019·2 cites·4 claims
- 0465US12310940B2Cell-permeable succinate compoundsAbliva Ab·Filed 2021·Granted May 27, 2025·0 cites·19 claims
- 0560US9670175B2Protected succinates for enhancing mitochondrial ATP-productionNeurovive Pharmaceuticals AB·Filed 2013·Granted Jun 6, 2017·2 cites·2 claims
- 0653US10857150B2Use of sanglifehrin macrocyclic analogues as anticancer compoundsNEUROVIVE PHARMACEUTICAL AB·Filed 2017·Granted Dec 8, 2020·0 cites·2 claims
- 0753US2024238255A1Kl1333 for use in medicineAbliva Ab·Filed 2022·Application pending·0 cites
- 0837US2015253306A1Mitochondrial toxicity testNEUROVIVE PHARMACEUTCAL AB·Filed 2013·Application pending·0 cites
- 0937US2019276481A1Liver Prodrugs of Mitochondrial Proton IonophoresNEUROVIVE PHARMACEUTICAL AB·Filed 2017·Application pending·0 cites
- 1036US11147789B2Cell-permeable succinate compoundsNEUROVIVE PHARMACEUTICAL AB·Filed 2015·Granted Oct 19, 2021·0 cites·21 claims
- 1127US2017105960A1Prodrugs of Succinic Acid for Increasing ATP ProductionNEUROVIVE PHARMACEUTICAL AB·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Magnus Joakim Hansson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →